AGUIAR ERIC
Insider CIK 1262325 · OCRX 10% owner · NVTA Director, 10% owner · BHVN Director · EIDX Director, 10% owner · BBIO Director · BMEA Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2026-06-22 | 2026-06-24 | 5,277 | — | $0 | 5,277 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award | 2026-06-22 | 2026-06-24 | 3,990 | — | $0 | 10,579 | SEC↗ |
| BMEA Biomea Fusion, Inc. | A Award deriv | 2026-06-10 | 2026-06-12 | 196,299 | — | $0 | 196,299 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2025-06-20 | 2025-06-24 | 8,425 | — | $0 | 8,425 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award | 2025-06-20 | 2025-06-24 | 6,589 | — | $0 | 6,589 | SEC↗ |
| BMEA Biomea Fusion, Inc. | A Award deriv | 2025-06-11 | 2025-06-13 | 91,970 | — | $0 | 91,970 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2024-06-21 | 2024-06-25 | 26,014 | — | $0 | 26,014 | SEC↗ |
| BMEA Biomea Fusion, Inc. | A Award deriv | 2024-06-12 | 2024-06-13 | 51,025 | — | $0 | 51,025 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2023-06-21 | 2023-06-23 | 51,501 | — | $0 | 51,501 | SEC↗ |
| BMEA Biomea Fusion, Inc. | A Award deriv | 2023-06-14 | 2023-06-16 | 6,989 | — | $0 | 6,989 | SEC↗ |
| NVTA Invitae Corp | A Award deriv | 2023-04-27 | 2023-05-01 | 28,901 | — | $0 | 28,901 | SEC↗ |
| NVTA Invitae Corp | A Award | 2023-04-27 | 2023-05-01 | 70,422 | — | $0 | 125,322 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2022-06-22 | 2022-06-24 | 104,921 | — | $0 | 104,921 | SEC↗ |
| BMEA Biomea Fusion, Inc. | A Award deriv | 2022-06-22 | 2022-06-24 | 23,867 | — | $0 | 23,867 | SEC↗ |
| NVTA Invitae Corp | A Award deriv | 2022-04-28 | 2022-05-02 | 16,100 | — | $0 | 16,100 | SEC↗ |
| NVTA Invitae Corp | A Award deriv | 2022-04-28 | 2022-05-02 | 5,700 | — | $0 | 5,700 | SEC↗ |
| NVTA Invitae Corp | A Award | 2022-04-28 | 2022-05-02 | 32,100 | — | $0 | 43,600 | SEC↗ |
| NVTA Invitae Corp | A Award | 2022-04-28 | 2022-05-02 | 11,300 | — | $0 | 54,900 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2021-06-17 | 2021-06-22 | 38,895 | — | $0 | 38,895 | SEC↗ |
| NVTA Invitae Corp | A Award deriv | 2021-04-30 | 2021-05-04 | 4,400 | — | $0 | 4,400 | SEC↗ |
| NVTA Invitae Corp | A Award deriv | 2021-04-30 | 2021-05-04 | 1,500 | — | $0 | 1,500 | SEC↗ |
| NVTA Invitae Corp | A Award | 2021-04-30 | 2021-05-04 | 8,500 | — | $0 | 8,500 | SEC↗ |
| NVTA Invitae Corp | A Award | 2021-04-30 | 2021-05-04 | 3,000 | — | $0 | 11,500 | SEC↗ |
| BMEA Biomea Fusion, Inc. | A Award deriv | 2021-04-15 | 2021-04-19 | 28,911 | — | $0 | 28,911 | SEC↗ |
| NVTA Invitae Corp | S Sale | 2020-12-16 | 2020-12-18 | 6,400 | $50.74 | $324.7K | 3,600 | SEC↗ |
| NVTA Invitae Corp | S Sale | 2020-12-16 | 2020-12-18 | 3,600 | $51.47 | $185.3K | 0 | SEC↗ |
| NVTA Invitae Corp | M Exercise | 2020-12-16 | 2020-12-18 | 10,000 | $24.16 | $241.6K | 10,000 | SEC↗ |
| NVTA Invitae Corp | M Exercise deriv | 2020-11-16 | 2020-11-18 | 10,000 | — | $0 | 0 | SEC↗ |
| NVTA Invitae Corp | M Exercise deriv | 2020-11-16 | 2020-11-18 | 10,000 | — | $0 | 0 | SEC↗ |
| NVTA Invitae Corp | M Exercise deriv | 2020-11-16 | 2020-11-18 | 10,000 | — | $0 | 0 | SEC↗ |
| NVTA Invitae Corp | M Exercise | 2020-11-16 | 2020-11-18 | 10,000 | $9.18 | $91.8K | 20,000 | SEC↗ |
| NVTA Invitae Corp | S Sale | 2020-11-16 | 2020-11-18 | 7,117 | $47.05 | $334.9K | 0 | SEC↗ |
| NVTA Invitae Corp | M Exercise | 2020-11-16 | 2020-11-18 | 10,000 | $11.13 | $111.3K | 30,000 | SEC↗ |
| NVTA Invitae Corp | S Sale | 2020-11-16 | 2020-11-18 | 22,883 | $46.36 | $1.06M | 7,117 | SEC↗ |
| NVTA Invitae Corp | M Exercise | 2020-11-16 | 2020-11-18 | 10,000 | $8.51 | $85.1K | 10,000 | SEC↗ |
| NVTA Invitae Corp | M Exercise deriv | 2020-07-15 | 2020-07-16 | 10,000 | — | $0 | 0 | SEC↗ |
| NVTA Invitae Corp | M Exercise | 2020-07-15 | 2020-07-16 | 10,000 | $8.08 | $80.8K | 10,000 | SEC↗ |
| NVTA Invitae Corp | S Sale | 2020-07-15 | 2020-07-16 | 3,171 | $33.44 | $106.0K | 6,829 | SEC↗ |
| NVTA Invitae Corp | S Sale | 2020-07-15 | 2020-07-16 | 6,829 | $34.24 | $233.8K | 0 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2020-06-02 | 2020-06-04 | 112,422 | — | $0 | 112,422 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | A Award deriv | 2020-05-27 | 2020-05-29 | 21,528 | — | $0 | 21,528 | SEC↗ |
| NVTA Invitae Corp | M Exercise deriv | 2020-05-02 | 2020-12-18 | 10,000 | — | $0 | 0 | SEC↗ |
| NVTA Invitae Corp | A Award deriv | 2020-04-30 | 2020-05-01 | 20,000 | — | $0 | 20,000 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise deriv | 2020-01-22 | 2020-01-24 | 1,250 | — | $0 | 2,500 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise deriv | 2020-01-22 | 2020-01-24 | 771 | — | $0 | 22,500 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | S Sale | 2020-01-22 | 2020-01-24 | 500 | $54.97 | $27.5K | 2,771 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise | 2020-01-22 | 2020-01-24 | 771 | $32.42 | $25.0K | 2,021 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | S Sale | 2020-01-22 | 2020-01-24 | 200 | $58.00 | $11.6K | 1,400 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | S Sale | 2020-01-22 | 2020-01-24 | 671 | $56.99 | $38.2K | 1,600 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | S Sale | 2020-01-22 | 2020-01-24 | 500 | $55.99 | $28.0K | 2,271 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | S Sale | 2020-01-22 | 2020-01-24 | 150 | $58.86 | $8.8K | 1,250 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise | 2020-01-22 | 2020-01-24 | 1,250 | $37.54 | $46.9K | 3,271 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise deriv | 2020-01-09 | 2020-01-10 | 30,000 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | S Sale | 2020-01-09 | 2020-01-10 | 30,000 | $56.39 | $1.69M | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise | 2020-01-09 | 2020-01-10 | 30,000 | $9.29 | $278.7K | 30,000 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise deriv | 2020-01-08 | 2020-01-10 | 1,250 | — | $0 | 3,750 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | A Award deriv | 2020-01-08 | 2020-01-10 | 5,000 | — | $0 | 5,000 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise | 2020-01-08 | 2020-01-10 | 1,250 | $55.91 | $69.9K | 1,250 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | A Award deriv | 2019-12-18 | 2019-12-20 | 12,000 | — | $0 | 12,000 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise deriv | 2019-12-16 | 2019-12-18 | 3,537 | — | $0 | 15,218 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise | 2019-12-16 | 2019-12-18 | 3,537 | $20.79 | $73.5K | 3,537 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | S Sale | 2019-12-16 | 2019-12-18 | 3,537 | $55.13 | $195.0K | 0 | SEC↗ |
| BBIO BridgeBio Pharma, Inc. | A Award deriv | 2019-12-12 | 2019-12-16 | 82,878 | — | $0 | 82,878 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise deriv | 2019-12-09 | 2019-12-11 | 4,072 | — | $0 | 18,755 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | S Sale | 2019-12-09 | 2019-12-11 | 4,072 | $55.11 | $224.4K | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise | 2019-12-09 | 2019-12-11 | 4,072 | $20.79 | $84.7K | 4,072 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise deriv | 2019-11-22 | 2019-11-22 | 1,250 | — | $0 | 3,750 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise | 2019-11-22 | 2019-11-22 | 1,250 | $37.54 | $46.9K | 1,250 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | S Sale | 2019-11-22 | 2019-11-22 | 1,250 | $55.24 | $69.0K | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise deriv | 2019-11-20 | 2019-11-22 | 6,729 | — | $0 | 23,271 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | S Sale | 2019-11-20 | 2019-11-22 | 6,729 | $52.20 | $351.3K | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise | 2019-11-20 | 2019-11-22 | 6,729 | $32.42 | $218.2K | 6,729 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise deriv | 2019-09-11 | 2019-09-13 | 10,000 | — | $0 | 20,000 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise | 2019-09-11 | 2019-09-13 | 10,000 | $25.51 | $255.1K | 10,000 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | S Sale | 2019-09-11 | 2019-09-13 | 10,000 | $45.00 | $450.0K | 0 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | P Buy | 2019-07-03 | 2019-07-08 | 882,353 | $29.90 | $26.38M | 24,575,501 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | A Award deriv | 2019-06-12 | 2019-06-13 | 21,528 | — | $0 | 21,528 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | P Buy | 2019-05-24 | 2019-05-29 | 1,103,848 | $25.93 | $28.62M | 23,693,148 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | A Award deriv | 2019-05-21 | 2019-05-23 | 18,000 | — | $0 | 18,000 | SEC↗ |
| NVTA Invitae Corp | A Award deriv | 2019-05-02 | 2019-05-06 | 10,000 | — | $0 | 10,000 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise deriv | 2019-02-04 | 2019-02-06 | 7,609 | — | $0 | 22,827 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise deriv | 2019-02-04 | 2019-02-06 | 10,000 | — | $0 | 30,000 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise | 2019-02-04 | 2019-02-06 | 17,609 | $42.54 | $749.1K | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise | 2019-02-04 | 2019-02-06 | 7,609 | $20.79 | $158.2K | 17,609 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise | 2019-02-04 | 2019-02-06 | 10,000 | $25.51 | $255.1K | 10,000 | SEC↗ |
| NVTA Invitae Corp | S Sale | 2018-11-27 | 2018-11-28 | 10,000 | $13.50 | $135.0K | 0 | SEC↗ |
| EIDX Eidos Therapeutics, Inc. | A Award deriv | 2018-07-01 | 2018-07-03 | 43,056 | — | $0 | 43,056 | SEC↗ |
| NVTA Invitae Corp | A Award deriv | 2018-06-22 | 2018-06-25 | 10,000 | — | $0 | 10,000 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | A Award deriv | 2018-05-01 | 2018-05-03 | 18,000 | — | $0 | 18,000 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | A Award deriv | 2017-12-07 | 2017-12-11 | 30,436 | — | $0 | 30,436 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | A Award deriv | 2017-09-05 | 2017-09-12 | 5,000 | — | $0 | 5,000 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | A Award deriv | 2017-08-04 | 2017-08-08 | 40,000 | — | $0 | 40,000 | SEC↗ |
| NVTA Invitae Corp | A Award deriv | 2017-05-02 | 2017-05-04 | 10,000 | — | $0 | 10,000 | SEC↗ |
| NVTA Invitae Corp | P Buy | 2016-11-18 | 2016-11-21 | 10,000 | $6.28 | $62.8K | 10,000 | SEC↗ |
| NVTA Invitae Corp | A Award deriv | 2016-05-05 | 2016-05-09 | 10,000 | — | $0 | 10,000 | SEC↗ |
| NVTA Invitae Corp | A Award deriv | 2015-11-04 | 2015-11-06 | 10,000 | — | $0 | 10,000 | SEC↗ |
| NVTA Invitae Corp | C Conversion deriv | 2015-02-18 | 2015-02-18 | 2,500,000 | — | $0 | 0 | SEC↗ |
| NVTA Invitae Corp | C Conversion deriv | 2015-02-18 | 2015-02-18 | 3,267,973 | — | $0 | 0 | SEC↗ |
| NVTA Invitae Corp | C Conversion deriv | 2015-02-18 | 2015-02-18 | 5,263,155 | — | $0 | 0 | SEC↗ |
| NVTA Invitae Corp | C Conversion deriv | 2015-02-18 | 2015-02-18 | 11,363,636 | — | $0 | 0 | SEC↗ |
| NVTA Invitae Corp | C Conversion | 2015-02-18 | 2015-02-18 | 3,732,460 | — | $0 | 3,732,460 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | J Other | 2013-07-15 | 2013-07-17 | 1,675,677 | $6.00 | $10.05M | 1,675,677 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | J Other | 2013-07-15 | 2013-07-17 | 762,892 | $6.00 | $4.58M | 762,892 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award deriv | 2012-10-01 | 2013-07-17 | 161,855 | $44.23 | $7.16M | 161,855 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award deriv | 2012-08-07 | 2013-07-17 | 31,835 | — | $0 | 31,835 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award deriv | 2012-03-30 | 2013-07-17 | 161,855 | $44.23 | $7.16M | 161,855 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award deriv | 2011-04-19 | 2013-07-17 | 25,000 | — | $0 | 25,000 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award deriv | 2010-02-11 | 2013-07-17 | 25,000 | — | $0 | 25,000 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award deriv | 2009-02-11 | 2013-07-17 | 25,000 | — | $0 | 25,000 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award deriv | 2006-02-06 | 2013-07-17 | 100,000 | — | $0 | 100,000 | SEC↗ |